Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01036971 · ClinicalTrials.gov registry record

Screening Protocol for the Evaluation of Potential Research Subjects

A clinical trial of Addiction, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
6,967
Enrollment target
1
Study location

NCT01036971: Completed study of Addiction, sponsored by National Institute on Drug Abuse (NIDA).

NCT01036971 is a study of Addiction that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 6,967 participants, above the 257-participant average among 16 other Addiction trials with a reported enrollment target (2611% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01036971, a study of Addiction, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
6,967 participants
Enrollment target
1
Study location

Study Summary

Background: \- The Neuroimaging Research Branch of the National Institute on Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen adolescents and adults who may be eligible for future research studies. Objectives: \- To identify, recruit, and screen participants for NIDA neuroimaging research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design: * Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. Adolescents who are eligible for further screening must bring a parent or guardian with them to the in-person interview. * The in-person interview may require up to five visits to the NIDA clinical center. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff. * During the screening process, participants will be explicitly asked for permission to recontact them after the 1-year duration of the screening protocol. For minors, both the adolescent and the parent/guardian must agree to future contact. * No clinical care will be provided under this protocol.

Primary Outcome

Screening for NIDA studies

Conditions Studied

Study Locations (1)

Maryland

  • National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore

Trial Details

FieldValue
Enrollment Target 6,967 participants
Start Date 2006-08-23

What the finished NCT01036971 record still lists

NCT01036971 is an observational study that tracks outcomes without assigning an intervention. Its 6,967 participants enrollment target places it among the larger protocols in the corpus, above the 257-participant average among 16 other Addiction trials with a reported enrollment target (2611% higher).

The record links to 1 condition, with Addiction appearing as the primary indexed condition, and to 0 interventions.

NCT01036971 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01036971 about?

NCT01036971 is a clinical study titled "Screening Protocol for the Evaluation of Potential Research Subjects". Background: \- The Neuroimaging Research Branch of the National Institute on Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addicti...

What is the current status of trial NCT01036971?

This trial is currently completed. The enrollment target is 6,967 participants. The study started on 2006-08-23.

What conditions does trial NCT01036971 study?

This clinical trial studies the following conditions: Addiction.

Who is sponsoring clinical trial NCT01036971?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01036971 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Addiction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01036971's enrollment target sits among peer trials

6,967 1st of 16 higher than 16 of 16 other Addiction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00260585 · 7,000 participants

    Esophageal Cancer Risk Registry

  • NCT04118660 · 7,000 participants

    Thoracic Specimen Registry

  • NCT07106879 · 7,000 participants

    Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

  • NCT07140744 · 7,000 participants · NA

    A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01036971, the US trial registry maintained by the National Library of Medicine. NCT01036971 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.